This was recently shown in a study where overexpressed ALCAT1 increased cardiolipin oxidation and mitochondrial dysfunction in the kidneys of patients with diabetic kidney disease, as well as in mouse and cell models of such diseases [35]. Here, LCLAT1 is linked to diabetic kidney disease.